Full Text
EE152 Cost-Effectiveness Analysis of Infliximab Versus Cyclosporine in Steroid-Refractory Acute Severe Ulcerative Colitis

Abstract

Authors

J Luong

Back to Volume 27, Supplemental Issue 6S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×